TOKU-E Company Announces Ultra-High Purity and Single Composition EvoPure(TM) Antimicrobials for Research and Manufacturing Applications

BELLINGHAM, Wash.--(BUSINESS WIRE)--TOKU-E Company (www.toku-e.com) has announced availability of their innovative ultra-high purity, single composition EvoPure line of antibiotics. Whether used for gene transfection and selection experiments, or in new drug discovery from old antibiotics, EvoPure antibiotics provide researchers more consistent and rapid results.

MORE ON THIS TOPIC